Breast Cancer News

Olanzapine reduced severe nausea more effectively than prochlorperazine for patients with refractory symptoms after chemotherapy, according to results of a randomized phase 3 trial.

Women with breast cancer are at risk for lymphedema long after their treatment concludes, according to study findings.

HER2-positive breast cancer has become one of the most treatable breast cancer types among patients of all ages, including those aged 40 years and younger.

Adjuvant radiotherapy reduced risk for local recurrence for a decade among women with early breast cancer who underwent breast-conserving surgery, results of a randomized phase 3 trial showed.

Datopotamab deruxtecan failed to extend OS vs. chemotherapy for adults with advanced breast cancer, according to the agent’s manufacturer.

SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy, researchers reported.

CHICAGO — The presence of breast arterial calcifications on routine mammograms may signal increased risk for atherosclerotic CVD later in life, according to research presented at the Annual Meeting of The Menopause Society.

PROVIDENCE, Rhode Island — The influence digital opinion leaders have on health care stakeholders and patients will continue to grow as new opportunities for education and collaboration arise, according to a presenter at the COSMO Meeting.

Greater utilization of genetic testing among men could have considerable benefits with regard to detection, risk management and personalized treatment of cancers, according to authors of a review published in JAMA Oncology.

Manuka honey may represent an alternative natural approach to reducing tumor growth in breast cancer, according to research conducted at UCLA Health Jonsson Comprehensive Cancer Center.